KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Operating Margin: 2012-2025

Historic Operating Margin for Sarepta Therapeutics (SRPT) over the last 11 years, with Jun 2025 value amounting to -49.16%.

  • Sarepta Therapeutics' Operating Margin fell 4896.00% to -49.16% in Q2 2025 from the same period last year, while for Jun 2025 it was -6.34%, marking a year-over-year decrease of 886.00%. This contributed to the annual value of 11.47% for FY2024, which is 3301.00% up from last year.
  • Sarepta Therapeutics' Operating Margin amounted to -49.16% in Q2 2025, which was down 300.18% from 24.56% recorded in Q4 2024.
  • In the past 5 years, Sarepta Therapeutics' Operating Margin ranged from a high of 24.56% in Q4 2024 and a low of -103.36% during Q1 2021.
  • Its 3-year average for Operating Margin is -13.03%, with a median of -0.19% in 2024.
  • Per our database at Business Quant, Sarepta Therapeutics' Operating Margin skyrocketed by 7,704bps in 2021 and then tumbled by 4,896bps in 2025.
  • Sarepta Therapeutics' Operating Margin (Quarterly) stood at -52.52% in 2021, then skyrocketed by 1,118bps to -41.34% in 2022, then surged by 4,755bps to 6.21% in 2023, then skyrocketed by 1,835bps to 24.56% in 2024, then tumbled by 4,896bps to -49.16% in 2025.
  • Its Operating Margin was -49.16% in Q2 2025, compared to 24.56% in Q4 2024 and 4.75% in Q3 2024.